Metabolic Solutions Development Company Identifies New Drug Target for Treatment of Type 2 Diabetes
06:05 EDT 9 Jun 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
PHILADELPHIA, June 9, 2012 /PRNewswire/ -- Researchers at Metabolic Solutions Development Company, LLC (MSDC) have identified a mitochondrial protein complex through which anti-diabetic drugs exert their insulin sensitizing effects when used to treat patie...
Other Sources for this Article
More From BioPortfolio on "Metabolic Solutions Development Company Identifies New Drug Target for Treatment of Type 2 Diabetes"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
